Skip to main content
Top
Published in: Medical Oncology 2/2012

01-06-2012 | Original Paper

Accuracy of positron emission tomography in mediastinal node assessment in coal workers with lung cancer

Authors: Ozkan Saydam, Mertol Gokce, Ali Kilicgun, Ozgur Tanriverdi

Published in: Medical Oncology | Issue 2/2012

Login to get access

Abstract

The purpose of this study was to explore the accuracy of 18F-fluorodeoxyglucose (FDG)-positron emission tomography/computed tomography (PET/CT) in the assessment of mediastinal lymph node in coal workers who had non-small cell lung cancer. We retrospectively reviewed 42 retired coal workers who had lung cancer without distant metastasis, between May 2007 and May 2010. Regarding the mediastinal lymph nodes, when the standard uptake value was greater than 2.5, it was considered “malignancy positive.” After histological examination of the mediastinal lymph nodes, anthracotic and metastatic ones were detected. The results of PET/CT were analyzed to determine its accuracy. Of these 42 patients, PET/CT detected 47 positive mediastinal lymph nodes in 24 patients with a mean SUV maximum of 6.2 (2.6–13.8). One hundred and thirty-one mediastinal lymph node foci were dissected. The sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of FDG-PET/CT in detecting nodal metastases were 84% (16/19), 65% (15/23), 66% (16/24), 83% (15/18), and 74% (31/42) on a per-patient basis, respectively. Mediastinal node staging with FDG-PET/CT in coal workers is insufficient due to the high false-positive rates due to the presence of pneumoconiosis. In these patients, an invasive technique such as mediastinoscopy seems mandatory for confirmation of ipsilateral or contralateral mediastinal lymph node metastasis.
Literature
1.
go back to reference Bayman NA, Blackhall F, Jain P, Lee L, Thatcher N, et al. Management of unresectable stage III non-small-cell lung cancer with combined-modality therapy: a review of the current literature and recommendations for treatment. Clin Lung Cancer. 2008;9:92–101.PubMedCrossRef Bayman NA, Blackhall F, Jain P, Lee L, Thatcher N, et al. Management of unresectable stage III non-small-cell lung cancer with combined-modality therapy: a review of the current literature and recommendations for treatment. Clin Lung Cancer. 2008;9:92–101.PubMedCrossRef
2.
go back to reference Tieu BH, Sanborn RE, Thomas CR Jr. Neoadjuvant therapy for resectable non-small cell lung cancer with mediastinal lymph node involvement. Thorac Surg Clin. 2008;18:403–15.PubMedCrossRef Tieu BH, Sanborn RE, Thomas CR Jr. Neoadjuvant therapy for resectable non-small cell lung cancer with mediastinal lymph node involvement. Thorac Surg Clin. 2008;18:403–15.PubMedCrossRef
3.
go back to reference Rohren EM, Turkington TG, Coleman RE. Clinical applications of PET in oncology. Radiology. 2004;231:305–32.PubMedCrossRef Rohren EM, Turkington TG, Coleman RE. Clinical applications of PET in oncology. Radiology. 2004;231:305–32.PubMedCrossRef
4.
go back to reference Konishi J, Yamazaki K, Tsukamoto E, Tamaki N, Onodera Y, et al. Mediastinal lymph node staging by FDG-PET in patients with non-small cell lung cancer: analysis of false-positive FDG-PET findings. Respiration. 2003;70:500–6.PubMedCrossRef Konishi J, Yamazaki K, Tsukamoto E, Tamaki N, Onodera Y, et al. Mediastinal lymph node staging by FDG-PET in patients with non-small cell lung cancer: analysis of false-positive FDG-PET findings. Respiration. 2003;70:500–6.PubMedCrossRef
5.
go back to reference Shim SS, Lee KS, Kim BT, Chung MJ, Lee EJ, et al. Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging. Radiology. 2005;236:1011–9.PubMedCrossRef Shim SS, Lee KS, Kim BT, Chung MJ, Lee EJ, et al. Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging. Radiology. 2005;236:1011–9.PubMedCrossRef
6.
7.
go back to reference Strauss LG. Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients. Eur J Nucl Med. 1996;23:1409–15.PubMedCrossRef Strauss LG. Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients. Eur J Nucl Med. 1996;23:1409–15.PubMedCrossRef
8.
go back to reference Reichert M, Bensadoun ES. PET imaging in patients with coal workers pneumoconiosis and suspected malignancy. J Thorac Oncol. 2009;4:649–51.PubMedCrossRef Reichert M, Bensadoun ES. PET imaging in patients with coal workers pneumoconiosis and suspected malignancy. J Thorac Oncol. 2009;4:649–51.PubMedCrossRef
9.
go back to reference Chong S, Lee KS, Chung MJ, Han J, Kwon OJ, et al. Pneumoconiosis: comparison of imaging and pathologic findings. RadioGraphics. 2006;26:59–77.PubMedCrossRef Chong S, Lee KS, Chung MJ, Han J, Kwon OJ, et al. Pneumoconiosis: comparison of imaging and pathologic findings. RadioGraphics. 2006;26:59–77.PubMedCrossRef
10.
go back to reference Aydin H. Evaluation of the risk of coal workers pneumoconiosis (CWP): a case study for the Turkish hard coal mining. Sci Res Essays. 2010;5:3289–97. Aydin H. Evaluation of the risk of coal workers pneumoconiosis (CWP): a case study for the Turkish hard coal mining. Sci Res Essays. 2010;5:3289–97.
11.
go back to reference Onito AA, Engel JM, Tanimu SB, Nguyen TC. Anthracosis and large mediastinal mass in a patient with healed pulmonary tuberculosis. Clin Med Res. 2010;8:99–103.CrossRef Onito AA, Engel JM, Tanimu SB, Nguyen TC. Anthracosis and large mediastinal mass in a patient with healed pulmonary tuberculosis. Clin Med Res. 2010;8:99–103.CrossRef
12.
go back to reference Rosell R, Gómez-Codina J, Camps C, Maestre J, Padille J, et al. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer. N Engl J Med. 1994;330:153–8.PubMedCrossRef Rosell R, Gómez-Codina J, Camps C, Maestre J, Padille J, et al. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer. N Engl J Med. 1994;330:153–8.PubMedCrossRef
13.
go back to reference Nomori H, Ohba Y, Yoshimoto K, Shibata H, Shiraishi K, et al. Positron emission tomography in lung cancer. Gen Thorac Cardiovasc Surg. 2009;57:184–91.PubMedCrossRef Nomori H, Ohba Y, Yoshimoto K, Shibata H, Shiraishi K, et al. Positron emission tomography in lung cancer. Gen Thorac Cardiovasc Surg. 2009;57:184–91.PubMedCrossRef
14.
go back to reference Gupta NC, Graeber GM, Bishop HA. Comparative efficacy of positron emission tomography with fluorodeoxyglucose in evaluation of small (<1 cm), intermediate (1 to 3 cm), and large (>3 cm) lymph node lesions. Chest. 2000;117:773–8.PubMedCrossRef Gupta NC, Graeber GM, Bishop HA. Comparative efficacy of positron emission tomography with fluorodeoxyglucose in evaluation of small (<1 cm), intermediate (1 to 3 cm), and large (>3 cm) lymph node lesions. Chest. 2000;117:773–8.PubMedCrossRef
15.
go back to reference Albes JM, Lietzenmayer R, Schott U, Schülen E, Wehrmann M, et al. Improvement of non-small-cell lung cancer staging by means of positron emission tomography. Thorac Cardiovasc Surg. 1999;47:42–7.PubMedCrossRef Albes JM, Lietzenmayer R, Schott U, Schülen E, Wehrmann M, et al. Improvement of non-small-cell lung cancer staging by means of positron emission tomography. Thorac Cardiovasc Surg. 1999;47:42–7.PubMedCrossRef
16.
go back to reference Vanhee D, Gossett P, Boitelle A, Wallaert B, Tonnee AB. Cytokines and cytokine network in cilicosis and coal workers’ pneumoconiosis. Eur Respir J. 1995;8:834–42.PubMed Vanhee D, Gossett P, Boitelle A, Wallaert B, Tonnee AB. Cytokines and cytokine network in cilicosis and coal workers’ pneumoconiosis. Eur Respir J. 1995;8:834–42.PubMed
17.
go back to reference Katabami M, Dusaka-Akita H, Honma K, Saitoh Y, Kimura K, et al. Pneumoconiosis-related lung cancer: preferential occurence from diffuse interstitial fibrosis-type pneumoconiosis. Am J Respir Crit Care Med. 2000;162:295–300.PubMed Katabami M, Dusaka-Akita H, Honma K, Saitoh Y, Kimura K, et al. Pneumoconiosis-related lung cancer: preferential occurence from diffuse interstitial fibrosis-type pneumoconiosis. Am J Respir Crit Care Med. 2000;162:295–300.PubMed
18.
go back to reference Alavi A, Gupta N, Alberini JL, Hickeson M, Adam LE, et al. Positron emission tomography imaging in nonmalignant thoracic disorders. Semin Nucl Med. 2002;32:293–321.PubMedCrossRef Alavi A, Gupta N, Alberini JL, Hickeson M, Adam LE, et al. Positron emission tomography imaging in nonmalignant thoracic disorders. Semin Nucl Med. 2002;32:293–321.PubMedCrossRef
19.
go back to reference Argani P, Ghossein R, Rosai J. Anthracotic and anthracosilicotic spindle cell pseudotumors of mediastinal lymph nodes: report of five cases of a reactive lesion that stimulates malignancy. Hum Pathol. 1998;29:851–5.PubMedCrossRef Argani P, Ghossein R, Rosai J. Anthracotic and anthracosilicotic spindle cell pseudotumors of mediastinal lymph nodes: report of five cases of a reactive lesion that stimulates malignancy. Hum Pathol. 1998;29:851–5.PubMedCrossRef
20.
go back to reference Billé A, Pelosi E, Skanjeti A, Arena V, Errico L, et al. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography. Eur J Cardiothorac Surg. 2009;36:440–5.PubMedCrossRef Billé A, Pelosi E, Skanjeti A, Arena V, Errico L, et al. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography. Eur J Cardiothorac Surg. 2009;36:440–5.PubMedCrossRef
21.
go back to reference Reed CE, Harpole DH, Posther KE, Woolson SL, Bowney RJ, et al. Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non-small cell lung cancer. J Thorac Cardiovasc Surg. 2003;126:1943–51.PubMedCrossRef Reed CE, Harpole DH, Posther KE, Woolson SL, Bowney RJ, et al. Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non-small cell lung cancer. J Thorac Cardiovasc Surg. 2003;126:1943–51.PubMedCrossRef
22.
go back to reference Schrevens L, Lorent N, Dooms C, Vansteenkiste J. The role of PET scan in diagnosis, staging, and management of non-small cell lung cancer. Oncologist. 2004;9:633–43.PubMedCrossRef Schrevens L, Lorent N, Dooms C, Vansteenkiste J. The role of PET scan in diagnosis, staging, and management of non-small cell lung cancer. Oncologist. 2004;9:633–43.PubMedCrossRef
23.
go back to reference Cerfolio RJ, Buddhiwardhan O, Bryant AS, Bass CS, Bartalucci AA, et al. The role of FDG-PET scan in staging patients with nonsmall cell carcinoma. Ann Thorac Surg. 2003;76:861–6.PubMedCrossRef Cerfolio RJ, Buddhiwardhan O, Bryant AS, Bass CS, Bartalucci AA, et al. The role of FDG-PET scan in staging patients with nonsmall cell carcinoma. Ann Thorac Surg. 2003;76:861–6.PubMedCrossRef
24.
go back to reference Lee PC, Port JL, Korst RJ, Liss Y, Meherally DN, et al. Risk factors for occult mediastinal metastases in clinical stage I non-small cell lung cancer. Ann Thorac Surg. 2007;84:177–81.PubMedCrossRef Lee PC, Port JL, Korst RJ, Liss Y, Meherally DN, et al. Risk factors for occult mediastinal metastases in clinical stage I non-small cell lung cancer. Ann Thorac Surg. 2007;84:177–81.PubMedCrossRef
Metadata
Title
Accuracy of positron emission tomography in mediastinal node assessment in coal workers with lung cancer
Authors
Ozkan Saydam
Mertol Gokce
Ali Kilicgun
Ozgur Tanriverdi
Publication date
01-06-2012
Publisher
Springer US
Published in
Medical Oncology / Issue 2/2012
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-011-9879-y

Other articles of this Issue 2/2012

Medical Oncology 2/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine